Facial Plast Surg
DOI: 10.1055/a-2689-1750
Original Research

Minimally Invasive Techniques for Nasal Valve Dysfunction: A Systematic Review and Meta-Analysis

1   Department of Rhinology and Facial Plastic Surgery, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
,
Filippo Cainelli
2   St. George's Hospital Medical School, London, United Kingdom
,
Luiza Farache Trajano
3   Department of Rhinology and Facial Plastic Surgery, Royal National ENT and Eastman Dental Hospitals, University College London Hospitals NHS Foundation Trust, London, United Kingdom
,
Peter J. Andrews
3   Department of Rhinology and Facial Plastic Surgery, Royal National ENT and Eastman Dental Hospitals, University College London Hospitals NHS Foundation Trust, London, United Kingdom
,
Hesham Saleh
1   Department of Rhinology and Facial Plastic Surgery, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
› Author Affiliations
Preview

Abstract

Background

Nasal valve dysfunction (NVD) is a prevalent cause of nasal obstruction, significantly impacting quality of life. In recent years, the emergence of office-based interventions has transformed the therapeutic landscape for this condition, offering patients a wider choice and less invasive options compared to traditional surgical methods, yet their comparative safety and efficacy remain to be fully established.

Methods

A systematic review and meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Four databases (PubMed, Scopus, Cochrane Library, and Ovid) were searched for original studies (2005–2025) assessing minimally invasive treatments for NVD with patient-reported outcomes. Random-effects meta-analyses evaluated changes in Nasal Obstruction Symptom Evaluation (NOSE) and Visual Analog Scale (VAS) scores.

Results

Fifteen studies comprising 546 patients were included, evaluating temperature-controlled radiofrequency (TCRF), bioabsorbable implants, intranasal suturing techniques, and nasal valve stenting. TCRF yielded a weighted mean difference (WMD) in NOSE scores of −44.68 (95% confidence interval [CI]: −51.23 to −38.13; p < 0.001), while bioabsorbable implants achieved a WMD of −39.91 (95% CI: −48.53 to −31.29; p < 0.001). Intranasal suturing demonstrated a VAS WMD of −4.36 (95% CI: −4.88 to −3.84; p < 0.001). All interventions surpassed minimal clinically important differences, with adverse events being relatively mild and transient. Improvements were sustained across all modalities over a follow-up period of 3 to 48 months (I 2 = 63.9–89.7%).

Conclusion

Minimally invasive techniques for NVD demonstrate statistically and clinically significant and durable symptom relief with favorable safety profiles. These interventions may offer viable alternatives to traditional surgical approaches, particularly in select patients seeking reduced morbidity and procedural complexity. Future research should prioritize randomized comparisons and standardized outcome metrics.

These authors contributed equally to this article and share first authorship.


Supplementary Material



Publication History

Received: 20 July 2025

Accepted: 23 August 2025

Article published online:
02 September 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA